Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1070567Generated: October 27, 2026

(2S)-1-tert-butoxycarbonyl-2(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)ethyl)-piperidine → 1-(N-cyclooctyl-gamma-tert-butyl-L-glutamyl)-2-(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)-ethyl)-piperidine

https://huagongshe.com/reaction/1070567

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(2S)-1-tert-butoxycarbonyl-2(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)ethyl)-piperidineHCID 20794986—
ReactantN-cyclooctyl-gamma-tert-butyl-L-glutamic acidHCID 20794995—
Product1-(N-cyclooctyl-gamma-tert-butyl-L-glutamyl)-2-(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)-ethyl)-piperidineHCID 2079497758%

Reaction Steps

N-Cyclooctyl-γ-tert-butyl-L-glutamic acid (8a, 344 mg, 1.1 mmol) and 2-(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)-ethyl)-piperidine (1g, 391 mg, 1.1 mmol) were coupled, using the methodology described in Example 1i, providing 380 mg (58%) of the title compound as a colourless oil. ESI-MS: 651.3 (M+H)+. Rf (silica gel; dichloromethane/methanol, 9:1, v/v): 0.23.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06903107B1
Source datasetuspto-grants-2005_06
ORD IDord-eb3c6f24aac54ee98e6130be4c9011d4
Source noteuspto-grants-2005_06